Metagenomics Global Market Report 2024

The metagenomics market has grown rapidly in recent years. It will grow from $1.72 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 16.0%. The growth observed in the historical period can be attributed to advancements in microbiome research, studies associating diseases with microbial factors, the demand for environmental monitoring, applications in agriculture and food-related processes, as well as the utilization of metagenomics in various biotechnological and industrial processes.

The metagenomics market is expected to see rapid growth in the next few years. It will grow to $3.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The anticipated growth in the forecast period can be attributed to the integration of metagenomics in precision medicine, increased understanding of microbial ecology, the promotion of One Health initiatives, applications in bioprospecting and drug discovery, and ongoing innovations in diagnostics and therapeutics. Major trends expected in this forecast period include technological advancements in sequencing methodologies, the integration of artificial intelligence (AI) and machine learning in metagenomic analysis, the exploration of single-cell metagenomics, the standardization of metagenomic data, and a growing focus on consumer wellness and personalized nutrition.

The significant rise in the incidence of infectious diseases is a key driver behind the robust growth of the metagenomics market. Infectious diseases, also known as transmissible diseases, are caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. These diseases can be transmitted from person to person or through other modes of transmission. Metagenomics plays a crucial role in the study of infectious diseases by analyzing the genetic material of microbial communities. It enables a comprehensive analysis of microbial communities associated with infectious agents, offering insights into their composition, genetic diversity, and potential interactions. For example, in October 2022, an article from the Pan American Health Organization reported approximately 10.6 million people falling ill with tuberculosis (TB) in 2021. Thus, the escalating prevalence of infectious diseases is a driving force behind the growth of the metagenomics market.

The burgeoning agriculture sector is poised to propel the metagenomics market forward. The agriculture sector encompasses various activities related to crop cultivation, livestock rearing, and the production of food, fiber, and other agricultural products. Metagenomics contributes to precision agriculture by providing data on microbial communities, enabling informed decisions on resource utilization, irrigation, and pest control. According to a report from the United States Department of Agriculture in November 2023, the combined contribution of agriculture, food, and related industries to the US gross domestic product (GDP) in 2021 was approximately $1.264 trillion. U.S. farms alone accounted for $164.7 billion, equivalent to around 0.7 percent of the country's GDP. The overall impact of agriculture on GDP exceeds this figure. Consequently, the growing agriculture sector acts as a catalyst for the metagenomics market's expansion.

A prominent trend in the metagenomics market is the adoption of technological advancements. Major companies in the market are actively embracing new genomics technologies to enhance their observational capabilities and maintain their market position. For instance, CD Genomics, a genomics services company based in the US, introduced the Long-Read Metagenomic Sequencing service in May 2023. This cutting-edge technology empowers researchers and scientists to gain a deeper and more accurate understanding of microbial communities. With features such as enhanced resolution, species identification, functional annotation, and comparative analysis, this advanced method is expected to revolutionize metagenomics research by providing unprecedented insights into microbial communities.

Leading companies in the metagenomics market are also focusing on developing innovative products, such as production-scale sequencers, to cater to larger customer bases, increase sales, and boost revenue. A production-scale sequencer is designed for high-throughput DNA sequencing tasks on a large scale. In September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus). These sequencers enable quicker, more potent, and environmentally sustainable sequencing. The NovaSeq X Plus, in particular, has the capacity to generate over 20,000 whole genomes annually, showcasing a throughput 2.5 times greater than its predecessors. The efficiency increase accelerates genomic discovery, enhances clinical insights, and contributes to a deeper understanding of diseases. Additionally, the NovaSeq X exhibits a strong commitment to environmental sustainability by significantly reducing packaging waste and weight, along with a 50% reduction in plastic usage compared to its predecessor, the NovaSeq 6000.

In June 2022, Illumina Inc. acquired IDbyDNA, a US-based biotechnology company specializing in metagenomic technology for infectious disease testing and pathogen surveillance, for an undisclosed amount. This acquisition is aimed at accelerating Illumina Inc.'s growth in the metagenomics market and expanding its range of solutions for customers.

Major companies operating in the metagenomics market report are Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Takara Bio USA Inc., BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation.

North America was the largest region in the global metagenomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of products associated with metagenomics include instruments, kits and reagents, and software and services. Instruments are tools and equipment used for sample collection, DNA and RNA extraction, and various workflows such as sequencing, pre-sequencing, and data analysis. Metagenomic applications span diverse fields, including environmental studies, clinical diagnostics, drug discovery, biotechnology, food and nutrition. These products are utilized by a range of end-users, including pharmaceutical industries, research laboratories, biotechnology companies, pathology laboratories, as well as academic and research institutes.

The metagenomics market research report provides metagenomics market statistics, including metagenomics industry global market size, regional shares, competitors with a metagenomics market share, detailed metagenomics market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics industry. This metagenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metagenomics market consists of revenues earned by entities by providing metagenomic services such as metatranscriptome sequencing, microbial genome sequencing, functional analysis, comparative metagenomics, and metatranscriptomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.